SEC Form 4 · accession 0000899243-18-015118
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2018 | M | 18,000 | — | A | 68,000 | D | |
| Common StockF2 | Jun 1, 2018 | P | 4,225 | $7.65 | A | 10,000 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jun 2, 2017 | M | 18,000 | A | — | — | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018.